Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802633 · ClinicalTrials.gov registry record · NA
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00802633 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 80 participants.
The verdict
NCT00802633, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.
Interventions
- DEVICE Stapling device during radical cystectomy
- DEVICE Ligasure tissue sealing device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802633
The ClinicalTrials.gov registry entry for NCT00802633 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stapling device during radical cystectomy is the first listed.
NCT00802633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802633 about?
NCT00802633 is a clinical study titled "Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?". Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.
What is the current status of trial NCT00802633?
This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2008-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00802633?
The interventions under investigation include: Stapling device during radical cystectomy (DEVICE), Ligasure tissue sealing device (DEVICE).
Who is sponsoring clinical trial NCT00802633?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.